What Preoperative Safety Protocols And Patient Screening Guidelines Help Minimize Tissue Necrosis And Hematoma Risks Prior To Aesthetic Facial Procedures? Expert Insights For Safe Practice

The safest preoperative protocol combines medical screening, medication review, blood-pressure control, nicotine cessation, and procedure-specific precautions. Before an aesthetic facial procedure, clinicians should identify factors that impair clotting, tissue perfusion, or wound healing; optimize controllable risks; and postpone treatment when safety conditions are not met. Laser procedures also require strict fire prevention, eye protection, sun-exposure management, and baseline documentation.

Tissue necrosis is primarily a perfusion and healing problem, while hematoma is primarily a bleeding and blood-pressure problem. A structured preoperative assessment should address both mechanisms rather than relying on a single checklist item.

Screen for Hematoma Risk

Measure and manage blood pressure

Blood pressure should be checked before treatment and interpreted in the context of the planned procedure, medical history, and local clinical policy. Poorly controlled hypertension increases bleeding and hematoma risk, particularly in procedures involving dissection, injection, or tissue elevation.

A systolic pressure above 150 mmHg should prompt reassessment and clinician review rather than automatic treatment. Patients should take prescribed antihypertensive medication as directed unless their treating clinician has provided different instructions.

Do not administer extra blood-pressure medication solely to meet a procedural threshold without appropriate medical supervision. Persistently elevated readings may require postponement and referral for medical management.

Review every medication and supplement

The preoperative history should specifically ask about:

Aspirin and other antiplatelet drugs
Prescription anticoagulants
NSAIDs
Vitamin E
Ginkgo biloba
Ginseng
Garlic supplements
Other over-the-counter products marketed for cardiovascular or “natural” health benefits

These agents may increase bruising or bleeding. Prescription anticoagulants and antiplatelet drugs must never be stopped automatically; the prescribing clinician should determine whether interruption is appropriate, when it should occur, and when treatment should resume.

For nonessential supplements and medications, the treating clinician should establish a written stop-and-restart plan. A blanket two-week discontinuation period may be appropriate for some agents in some protocols, but it is not safe as a universal rule.

Identify bleeding history

Ask about unusual bruising, prolonged bleeding after dental work or surgery, nosebleeds, heavy menstrual bleeding, known bleeding disorders, and prior postoperative hematomas. The clinician should also determine whether laboratory testing is indicated based on the history and procedure risk.

Routine testing is not a substitute for a careful history, and normal results do not eliminate all bleeding risk.

Protect Tissue Perfusion

Require nicotine cessation

Smoking and nicotine exposure impair microvascular perfusion and wound healing. They can substantially increase the risk of ischemia, delayed healing, infection, and skin-flap necrosis, especially when tissue has been surgically elevated or its blood supply is otherwise reduced.

Patients should stop cigarettes, vaping, nicotine pouches, chewing tobacco, and other nicotine products before treatment. A minimum of two weeks before and after the procedure is a common high-risk protocol, although longer cessation may be recommended for surgery or patients with additional vascular risks.

Nicotine status should be documented without relying only on the patient’s description when the procedure has a meaningful risk of tissue ischemia. Treatment should be postponed when the patient cannot meet the clinic’s cessation requirements.

Screen for vasospasm and vascular disease

Ask about Raynaud’s phenomenon, cold- or stress-induced color changes, peripheral vascular disease, prior vascular events, and unexplained episodes of tissue pallor or discoloration. These findings may indicate impaired or unstable microvascular circulation.

Patients with connective-tissue disease, autoimmune disease, diabetes, or other conditions associated with impaired healing require individualized assessment. Their condition, medications, and disease control may affect whether treatment is appropriate and how energy delivery or surgical planning should be modified.

Assess healing capacity

The consultation should cover diabetes control, immune suppression, prior radiation, active infection, poor wound healing, keloid or hypertrophic scarring, and previous complications from cosmetic procedures. These factors can alter tissue resilience and recovery.

Examine the treatment area for infection, inflammation, open wounds, dermatitis, compromised skin integrity, or previous filler and surgical changes. Elective treatment should generally be deferred until active local disease has resolved.

Apply Procedure-Specific Safety Controls

Use laser fire precautions

For laser procedures, the treatment area should be cleaned before treatment, and any alcohol-based antiseptic must be allowed to fully evaporate. Residual alcohol or other flammable liquid can ignite when exposed to a high-energy laser beam.

The room should be checked for flammable materials, and the operator should follow the laser system’s safety and fire-control requirements. These precautions are separate from hematoma and necrosis screening but are essential to overall preoperative safety.

Protect every person’s eyes

All room occupants require protective eyewear appropriate to the laser’s wavelength. Ordinary safety glasses are not an adequate substitute for wavelength-specific protection.

The patient’s eyewear should be fitted and positioned before activation, and staff should verify that everyone in the controlled area understands the laser safety requirements.

Control recent ultraviolet exposure

Patients should avoid significant sun exposure before laser treatment and use broad-spectrum sunscreen as instructed. Recent tanning or sunburn can increase the risk of pigmentary complications and may affect how safely treatment parameters can be selected.

The operator should document relevant sun exposure, tanning products, and the condition of the skin on the treatment day. Treatment may need to be delayed when the skin is sunburned or substantially tanned.

Document the baseline

Pre-treatment photographs provide an objective record of the patient’s baseline appearance. Images should be consistent in lighting, positioning, and framing so that postoperative bruising, swelling, discoloration, or tissue changes can be evaluated accurately.

Documentation should also include the treatment area, planned procedure, relevant risk factors, medication instructions, consent, and any decision to postpone or modify treatment.

Establish a Clear Day-of-Procedure Checklist

Confirm readiness

Before beginning, the team should confirm:

Blood pressure has been measured and reviewed
Medication and supplement instructions have been reconciled
Nicotine cessation status has been documented
The patient has no active infection or untreated skin problem
Relevant vascular, connective-tissue, and healing conditions have been assessed
The treatment plan and risks have been reviewed
Baseline photographs have been obtained when appropriate
Laser eyewear and room controls are in place
Alcohol-based products have completely dissipated before laser activation

A checklist is most effective when it gives the clinician authority to postpone treatment. It should not become a documentation exercise that allows unresolved risks to pass unnoticed.

Define escalation criteria

The clinic should specify when treatment requires medical clearance, additional testing, a modified plan, or postponement. Examples include uncontrolled hypertension, active nicotine use, unexplained bleeding, recent changes to anticoagulant therapy, significant vascular disease, and suspected infection.

Patients should receive written instructions describing which medications to continue, which nonessential agents to stop, when to resume them, and which symptoms require urgent contact after treatment.

Understanding the Trade-offs

Avoid overly broad medication rules

Stopping aspirin, anticoagulants, or antiplatelet therapy can reduce procedural bleeding but may create a serious risk of stroke, heart attack, thrombosis, or other complications. The correct decision depends on why the medication was prescribed and on the bleeding risk of the planned procedure.

The treating clinician and prescribing professional should balance those risks. Patients should not independently discontinue prescribed therapy.

Do not treat a single blood-pressure value in isolation

A high reading can reflect anxiety, pain, recent caffeine, or an underlying medical problem. Conversely, a single acceptable reading does not eliminate bleeding risk from medication, coagulopathy, or an invasive technique.

Blood pressure is one part of the risk assessment. Persistent or severe elevation should be medically evaluated before elective treatment.

Recognize that risk varies by procedure

A superficial laser treatment, injectable procedure, deep-plane surgery, and tissue-flap operation do not carry identical risks. The need for laboratory testing, medication management, nicotine abstinence, and medical clearance should be proportional to the procedure’s invasiveness and the patient’s health.

Protocols should therefore use a baseline checklist plus procedure-specific additions. Applying the same rules to every facial treatment can either create unnecessary barriers or fail to address high-risk situations.

Making the Right Choice for Your Goal

A safe protocol should translate identified risks into a documented decision to proceed, modify the plan, obtain clearance, or postpone treatment.

If your primary focus is minimizing hematoma: Control significant hypertension, obtain a complete medication and supplement history, and coordinate any change to prescribed anticoagulant or antiplatelet therapy with the prescriber.
If your primary focus is preventing tissue necrosis: Enforce nicotine cessation, screen for vasospastic and connective-tissue disorders, assess healing capacity, and avoid treatment when perfusion or skin integrity is compromised.
If your primary focus is laser safety: Confirm wavelength-specific eye protection, remove or fully evaporate flammable products, assess recent ultraviolet exposure, and document the baseline treatment area.
If your primary focus is clinic-wide consistency: Use a procedure-specific checklist with explicit postponement and medical-clearance criteria.

The most reliable prevention strategy is disciplined risk identification before treatment, followed by individualized optimization rather than automatic one-size-fits-all instructions.

Summary Table:

Risk Factor	Key Actions
Blood Pressure	Measure pre-op; >150 mmHg prompts reassessment; manage hypertension.
Medications/Supplements	Screen for anticoagulants, NSAIDs, vitamins; coordinate with prescriber.
Nicotine Use	Mandatory cessation ≥2 weeks before/after; document status.
Bleeding History	Ask about bruising, bleeding; consider labs if indicated.
Vascular Health	Screen for Raynaud's, vascular disease; assess healing capacity.
Laser Safety	Ensure eye protection, evaporate alcohol, check for flammables.
Sun Exposure	Avoid recent tanning; use sunscreen; delay if sunburned.
Baseline Documentation	Take consistent photos for post-op comparison.

Elevate your aesthetic practice with BELIS's professional-grade devices. From laser and IPL to body sculpting and skin care, our advanced technology supports safe, effective treatments. Contact us today to learn how we can help you achieve optimal patient outcomes and grow your business, whether you're a clinic or distributor seeking reliable partners.